DNAJC19P8

Across TCGA pan-cancer cohorts, DNAJC19P8 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DNAJC19P8’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where DNAJC19P8 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DNAJC19P8 is over-expressed in tumor.

HNSC, BRCA, and LUSC are the cancer types where DNAJC19P8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DNAJC19P8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.088	.021	6	view →
BRCA	Female	All	+0.109	.017	4	view →
LUSC	All	All	+0.061	.008	4	view →
STAD	Male	All	+0.345	.006	3	view →
LUAD	All	All	+0.132	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

DNAJC19P8–HNSC

Open the HNSC breakdown →